Skip to main content
Equibles
INNV logo

INNV · InnovAge Holding Corp.

Track INNV — free

Use INNV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.75 -0.02 (-0.19%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$1.46B
Shares
135.74M

INNV metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.75
Market cap
$1.46B

Price action

19 metrics
Price change (1W)
-1.0%
Price change (30D)
-1.4%
Price change (3M)
+47.3%
Price change (6M)
+19.7%
Price change (YTD)
+107.1%
Price change (1Y)
+194.5%
Trailing year
Price change (5Y)
-29.6%
52-week high
$12.11
52-week low
$3.65
Change from 52-week high
-11.2%
Change from 52-week low
+194.5%
Annualized volatility
79.6%
Beta
0.9
RSI (14D)
46.6
Price vs SMA 50
-4.2%
Price vs SMA 200
+30.3%
Avg volume (3M)
318,102
Relative volume
0.5
Average dollar volume
$3.37M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
135.74M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 68.9%
EV / EBITDA
162.1×
reciprocal yield 0.6%
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.0%
P / book
6.4
reciprocal yield 15.7%
FCF yield
—
TTM · current market cap
Buyback yield
5.3%
P / FCF
—
P / operating cash flow
27.8
reciprocal yield 3.6%
Earnings yield
-0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 117.6%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 109.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
38.5×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
165.5×
reciprocal yield 0.6%
EV / EBITDA historical average (5Y)
93.5×
reciprocal yield 1.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-09-08
Last earnings
2026-05-05

Profitability

9 metrics
Gross margin
21.8%
Operating margin
-1.0%
Trailing 12 months
Net margin
-1.2%
Gross profit (TTM)
$206.49M
Operating profit (TTM)
−$9.68M
Net income (TTM)
−$11.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.08
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+15.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$949.17M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+6.9%
Revenue CAGR (5Y)
+8.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-3.6%

Quality

14 metrics
Return on equity
-5.1%
Return on assets
-2.1%
Debt / equity
0.3
Current ratio
1.0
EBITDA (TTM)
$8.50M
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
-9.5
Return on invested capital
—
Trailing 12 months
Net cash
$80.62M
Latest balance sheet
Cash & equivalents
$95.54M
Total assets
$547.39M
Total debt
$57.97M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$52.43M
Capital expenditures (TTM)
$9.86M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$6.86M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
107
13F filer change QoQ
+3
Institutional ownership
13.6%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1834376 CUSIP 45784A104 13F (30d) 73 filings 73 filers Visit website Investor relations